Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT07124546
Status
Recruiting
Apply to this trial

Conditions

  • Malignant Hepatobiliary Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Acceptance and Commitment Therapy — BEHAVIORAL
    Attend ACT-HBC telehealth group sessions
  • Questionnaire Administration — OTHER
    Ancillary studies
  • Telemedicine — OTHER
    Attend ACT-HBC telehealth group sessions

Study Details

This clinical trial studies whether Acceptance and Commitment Therapy for patients with hepatobiliary cancers (ACT-HBC) can be used to help improve cancer distress. Patients with hepatobiliary cancer (HBC) often experience high levels of distress and reductions in quality of life. ACT-HBC is a behavioral intervention tailored to patients with HBC. It helps patients cope with difficult thoughts and emotions while staying connected to what matters most in life, which may be an effective way to improve cancer distress.

Key Dates

Start date
May 28, 2025
Status verified
Aug 2025
Primary completion
May 30, 2027
Completion
May 30, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Supportive care (ACT-HBC)
    Patients attend ACT-HBC telehealth group sessions over 2 hours QW for 8 weeks.

Primary Outcome Measure

Patient satisfaction [ Time Frame: At 8 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Sofia Hammel
[email protected]
507-255-0760
Deanna Hofschulte
[email protected]
507-255-2972
Carrie A. Bronars, PhD, LP (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies